articleArticles in this in-depth focus discuss the development and delivery…
25 June 2021 | By European Pharmaceutical Review
Articles in this in-depth focus discuss the development and delivery challenges associated with mRNA vaccine technology and explore how investing in the off-patent drug sector can benefit both pharma innovation and patient care.